Patent details

91888 Product Name: L'apixaban et ses sels pharmaceutiquement acceptables dans toutes les formes bénéficiant de la protection du brevet initial.

Basic Information

Publication number:
91888
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP027758432
Legal Status:
Active
Application number:
91888
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
28/07/2023
SPC Extension Agent Name:
Patent42 SA
SPC Extension Status:
Granted
SPC Extension Grant Date:
05/02/2026
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/11/691/001-005 - Eliquis - apixaban
Marketing Authorization Type:
Marketing Authorization Date:
20/05/2011
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
19/10/2011
First Marketing Authorization date:
20/05/2011
Grant date:
19/12/2011
Activation date:
17/09/2022
Publication date:
19/12/2011
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
20/05/2026
SPC Extension Expiration:
20/11/2026
Rejection date:
Withdrawal date:

Owner

From:
29/05/2019
 
 

Name:
Bristol-Myers Squibb Holdings Ireland Unlimited Company
Address:
Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)

History of Owners

From:
31/08/2016
To:
29/05/2019

Name:
BRISTOL-MYERS SQUIBB HOLDINGS IRELAND
Address:
HINTERBERGSTRASSE 16, 6312 STEINHAUSEN, Switzerland (CH)

From:
19/10/2011
To:
30/08/2016

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, Princeton NJ 08543-4000, United States (US)

Agent

1

Name:
Patent42 SA
From:
23/01/2026
Address:
5, rue Dicks, 4081, Esch-sur-Alzette, Luxembourg (LU)
To:

2

Name:
MARKS & CLERK LLP
From:
19/10/2011
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:
23/01/2026

Inventor

1

Name:
ORWAT Michael
Address:
United States (US)

2

Name:
KOCH Stephanie
Address:
United States (US)

3

Name:
QUAN Mimi
Address:
United States (US)

4

Name:
LI Yun-Long
Address:
United States (US)

5

Name:
PINTO Donald
Address:
United States (US)

6

Name:
HAN Wei
Address:
United States (US)

7

Name:
LAM Patrick
Address:
United States (US)

8

Name:
QIAO Jennifer, X.
Address:
United States (US)

Publication

Bulletin

1

Bulletin Heading:
SPC4
Bulletin edition number:
2019/02
Publication date:
22/02/2019
Description:
Section F : Correction of granted supplementary protection certificates – I9 publication

2

Bulletin Heading:
CO
Bulletin edition number:
2019/08
Publication date:
10/07/2019
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

3

Bulletin Heading:
SPC3
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

4

Bulletin Heading:
SPCX2
Bulletin edition number:
2026/04
Publication date:
03/03/2026
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

5

Bulletin Heading:
SPCX1
Bulletin edition number:
2026/03
Publication date:
05/02/2026
Description:
Section G : Applications for extensions for pediatric use – I1E publication

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20190000222A
Date Registered:
29/05/2019
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Bristol-Myers Squibb Holdings Ireland Unlimited Company
Address:
Hinterbergstrasse 16, 6312, Steinhausen, Switzerland (CH)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
12/09/2025
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
440 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
03/01/2019 Publication 1
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56
04/06/2019 Outgoing Correspondence 1
03/01/2019 Outgoing Correspondence 1
29/05/2019 Request For Change 1
12/10/2016 Incoming Correspondence (Post) 7
13/07/2018 Incoming Correspondence (Post) 2
05/02/2026 Outgoing Correspondence 2
05/02/2026 Incoming Correspondence (Email) 2
05/02/2026 General Document 1
05/02/2026 General Document 1
05/02/2026 Marketing authorization 3
27/01/2026 Publication 1
05/02/2026 Publication 1
05/02/2026 Certificate 1
27/01/2026 FNET_DC_FRONTPAGE 1
06/02/2026 Outgoing Correspondence 1
23/01/2026 Outgoing Correspondence 2
23/01/2026 General Document 1
23/01/2026 General Document 1
23/01/2026 General Document 1
23/01/2026 Incoming Correspondence (Email) 2
23/01/2026 Request For Change 1
23/01/2026 Request For Change 1
26/01/2026 Outgoing Correspondence 1
27/01/2026 Outgoing Correspondence 1
27/01/2026 Outgoing Correspondence 1
28/07/2023 Paediatric investigation plan 4
28/07/2023 Application Form 3
28/07/2023 Summary of the product caracteristics 89
28/07/2023 General Document 2
28/07/2023 Incoming Correspondence (Post) 2
28/07/2023 Paediatric investigation plan 1